THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC
Mission Statement
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs.
Financial Overview — FY 2025
Compared with Peers
FY 2025| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
78.9% | 85.4% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
3.4% | 11.1% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
17.6% | 1.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
16.6 mo | 10.0 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
23.6% | 23.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
72.9% | 92.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
25.5% | 7.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-2.7% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
5.1% | 3.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $36.5M | $34.7M | $48.0M | 78.9% | 80 |
| 2024 | $29.1M | $35.6M | $50.0M | 81.5% | 72 |
| 2023 | $34.0M | $41.9M | $56.3M | 83.5% | 78 |
| 2022 | $45.0M | $38.3M | $63.7M | 84.2% | 80 |
| 2021 | $42.3M | $37.6M | N/A | — | 74 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.